ArticleScientific reports2023

Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration.

Hoseok Yeom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.